Results 21 to 30 of about 3,493 (178)

Situation of anti-fungal resistance of species of the genus Candida in Peru

open access: yesRevista Peruana de Medicina Experimental y Salud Pública, 2018
We are currently witnessing a constant and ongoing change of the epidemiological pictures of yeast resistance to antifungal agents, related to the type of host, etiology of the disease, the microorganism involved, and its mechanisms of resistance.
Susana Zurita Macalupú
doaj   +1 more source

Cuerpo extraño vegetal intrabronquial con colonización por Aspergillus [PDF]

open access: yesRevista SOCAMPAR, 2019
La aspiración de cuerpo extraño en la vía aérea es poco frecuente en adultos. Es poco probable que se relate el episodio de atragantamiento espontáneamente como antecedente claro y suele pasar inadvertido.
Arroyo-Cózar M,   +2 more
doaj  

FUSARIOSE EM PACIENTE COM LINFOMA LINFOBLÁSTICO T - RELATO DO CASO

open access: yesHematology, Transfusion and Cell Therapy, 2023
Objetivo: Relatar um caso de infecção fúngica invasiva por fusarium em paciente com Linfoma Linfoblástico T. Relato de caso: P. F. M. C., 38 anos, sexo feminino, deu entrada em nosso serviço em fevereiro de 2021 com diagnóstico de Linfoma Linfoblástico T
FC Domingos   +8 more
doaj   +1 more source

Trichosporon asahii an emerging etiologic agent of fungal infection and colonization in heart failure patients in intensive care unit: case report and literature review [PDF]

open access: yes, 2008
JUSTIFICATIVA E OBJETIVOS: As infecções fúngicas por Trichosporon Asahii têm sido cada vez mais freqüentes nas últimas duas décadas. Quadros graves com alta mortalidade são tradicionalmente descritos em pacientes neutropênicos com câncer. Recentemente, a
ARAÚJO, Hélia Beatriz Nunes de   +7 more
core   +2 more sources

Voriconazole

open access: yesReactions Weekly, 2006
Voriconazole (VRZ) is a second-generation triazole antifungal agent active against many species of Aspergillus and Candida and acts by inhibiting ergosterol synthesis. VRZ has less nephrotoxicity and less infusion-related toxicity than that of Amphotericin B. Oral and parental formulation have similar pharmacokinetics and thus oral formulation shortens
Rahul, Naithani, Rajat, Kumar
openaire   +3 more sources

Brain Abcess due to Cladophialophora bantiana: first case in Portugal [PDF]

open access: yes, 2015
Clinical case reporting a brain abscess caused by Cladophialophora bantiana in an male patient with 56 years old. This is a rare case of a brain abscess caused by this species. Few cases have been reported in the literature world-wide, being this one the
Brizido, H.   +6 more
core   +1 more source

PS1214 INFECTIOUS COMPLICATIONS FOLLOWING ARI‐0001 CELL (A3B1:CD8:4–1BB:CD3Z CART19) TREATMENT IN ADULT AND PEDIATRIC PATIENTS WITH CD19+ RELAPSED / REFRACTORY MALIGNANCIES

open access: yesHemaSphere, Volume 3, Issue S1, Page 553-554, June 2019., 2019
Background: Several chimeric antigen receptor products targeting CD19 are either approved or in development for the treatment of acute lymphoblastic leukemia (ALL) and non‐Hodgkin's lymphoma (NHL). Nevertheless, information on infections and immune impairment caused by this procedure (lymphodepletion chemotherapy, neutropenia, B‐cell aplasia and ...
V. Ortiz‐Maldonado   +21 more
wiley   +1 more source

Endocarditis, Meningitis and Pneumocystis Pneumonia [PDF]

open access: yes, 2016
Infective endocarditis (IE) is associated with high morbidity and mortality despite advances in antibiotic and surgical treatment. Systemic embolism occurs in up to 49% of IE patients and may involve the major arteries, limb arteries, viscera and the ...
Andrade, Sérgio   +4 more
core   +2 more sources

EHA2021 Virtual Congress Abstract Book

open access: yes, 2021
HemaSphere, Volume 5, Issue S2, June 2021.
wiley   +1 more source

PS1215 SAFETY AND TOLERABILITY OF ALLOGENEIC, OFF‐THE SHELF PLACENTAL NATURAL KILLER CELLS (PNK 007) IN PHASE 1 MULTIPLE MYELOMA AND ACUTE MYELOID LEUKEMIA STUDIES (NCT02955550 AND NCT02781467)

open access: yesHemaSphere, Volume 3, Issue S1, Page 554, June 2019., 2019
Background: PNK‐007 is an allogeneic, off‐the‐shelf cell therapy enriched for CD56+/CD3‐ NK cells expanded from placental CD34+ cells. PNK‐007 exhibits cytotoxicity against various cancer cell types. Aims: Characterize the safety and tolerability of PNK‐007 single‐infusion in subjects (subj) with relapsed/refractory (r/r) AML (completed) and with r/r ...
S. Koppisetti   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy